Michael Gelband’s Teva Pharmaceuticals TEVA Stock Holding History

Michael Gelband’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$953K	Buy	+28,119	New	+$937K	0.01%	1090
2026 Q1	–	Sell	-54,508	Closed	-$1.7M	–	2087
2025 Q4	$1.7M	Buy	+54,508	New	+$1.34M	0.01%	822
2023 Q3	–	Sell	-18,265	Closed	-$138K	–	2134
2023 Q2	$138K	Sell	18,265 -331,735	-95%	-$2.69M	﹤0.01%	1731
2023 Q1	$3.1M	Buy	350,000 +333,869	+2,070%	+$3.3M	0.03%	703
2022 Q4	$147K	Sell	16,131 -9,267	-36%	-$80.9K	﹤0.01%	1492
2022 Q3	$205K	Buy	25,398 +8,100	+47%	+$71.6K	﹤0.01%	1631
2022 Q2	$130K	Buy	+17,298	New	+$151K	﹤0.01%	1717
2022 Q1	–	Sell	-92,823	Closed	-$744K	–	2677
2021 Q4	$744K	Buy	+92,823	New	+$838K	0.01%	1221
2021 Q3	–	Sell	-52,641	Closed	-$521K	–	2619
2021 Q2	$521K	Buy	+52,641	New	+$557K	0.01%	1363
2020 Q4	–	Sell	-58,858	Closed	-$530K	–	2371
2020 Q3	$530K	Buy	+58,858	New	+$623K	0.01%	983
2020 Q2	–	Sell	-22,864	Closed	-$205K	–	2026
2020 Q1	$205K	Sell	22,864 -19,589	-46%	-$201K	0.01%	780
2019 Q4	$416K	Buy	42,453 +22,253	+110%	+$199K	0.01%	974
2019 Q3	$139K	Buy	+20,200	New	+$155K	﹤0.01%	1195
2019 Q1	–	Sell	-135,144	Closed	-$2.08M	–	769
2018 Q4	$2.08M	Buy	+135,144	New	+$2.77M	0.15%	61

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Michael Gelband's TEVA Position: Q2 2026 in Review

Michael Gelband opened a new position in Teva Pharmaceuticals (TEVA) in Q2 2026: 28,119 shares worth $953K. The stake represents 0.01% of the portfolio and ranks #1090 among its holdings. This is a return to the name: Michael Gelband previously reported a position in TEVA as recently as Q4 2025.

Michael Gelband first reported a position in TEVA in Q4 2018 and has held it in 14 quarters since. The position peaked at $3.1M in Q1 2023. 671 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Michael Gelband held 28,119 shares of Teva Pharmaceuticals worth $953K as of Q2 2026.
Teva Pharmaceuticals was a new Michael Gelband position in Q2 2026.
Teva Pharmaceuticals made up 0.01% of Michael Gelband's portfolio in Q2 2026, its #1090 holding.
Michael Gelband first reported a position in Teva Pharmaceuticals in Q4 2018 and has held it in 14 quarters since.
Michael Gelband's Teva Pharmaceuticals position peaked at $3.1M in Q1 2023.
671 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.